Medpage Today on MSN22d
Therapeutic HPV Vaccine Effective in Reducing Precancerous Cervical Lesions
An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive cervical intraepithelial neoplasia grade 3 (CIN3), according to results from ...
infectiousdiseaseadvisor.com12d
Therapeutic Vaccine Shows Preliminary Safety, Effectiveness for HPV16+ Cervical Precancerous Condition
HealthDay News — For patients with human papillomavirus (HPV) type 16 (HPV16)-positive cervical intraepithelial neoplasia grade 3 (CIN3), vaccination with a replication-incompetent Semliki Forest ...
cidrap.umn10d
Meta-analysis finds high rates of non-vaccine, high-risk HPV cervical infections, even in vaccinated women
But rates of types 31/33/45, 47, and 45 were lower in vaccinated women, which the authors said suggests that the vaccines ...
NDTV28d
Women's Health: Cervical Cancer Linked To HPV? Keep These Things In Mind To Stay Safe
HPV is a group of viruses, and certain strains, such as HPV-16 and HPV-18, are responsible for nearly 70% of cervical cancer cases. HPV spreads through sexual contact and infects the cervix ...
Medscape8d
HPV Vaccine ‘Very Promising’ for Nixing Precancerous Lesions
A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...
中国日报网22d
HPV vaccine made available for males
The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...